BIO-TECHNE Corp vs Sprott Uranium Miners ETF — how do they compare? BIO-TECHNE Corp trades at $71.63 (market cap $11.16B), while Sprott Uranium Miners ETF trades at $50.32. The key difference: BIO-TECHNE Corp pays a 0.45% dividend while Sprott Uranium Miners ETF pays none, and BIO-TECHNE Corp is trading nearer its 52-week high, Sprott Uranium Miners ETF nearer its low. Which is the better fit depends on your goals.
| TECH | URNM | |
|---|---|---|
Market Cap | $11.16B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $72.12 | $83.99 |
52-Week Low | $43.31 | $44.14 |
Enterprise Value | $11.24B | — |
Dividend Yield | 0.45% | — |
Trailing returns across standard periods
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →URNM is a pure-play ETF that invests in the global uranium industry. It provides exposure to companies involved in the mining, exploration, and production of uranium, as well as physical uranium holdings, with top assets like Cameco, Uranium Energy Corp, and the Sprott Physical Uranium Trust.
Read more on URNM →